| |
| |
|
| Insider
Information: |
Akkaraju Srinivas |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
19 |
|
| Direct
Shares |
3,961,226 |
|
|
Indirect Shares
|
37,470,445 |
|
|
| Direct
Value |
$19,702,089 |
|
|
|
Indirect Value
|
$276,102,231 |
|
|
| Total
Shares |
41,431,671 |
|
|
| Total
Value |
$295,804,320 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
3
|
|
Stock
price went up :
|
4
|
1
|
| Stock
price went down : |
1
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
4.0
|
| Percentage
Gain/Loss : |
 28.4%
|
 -84.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmos Corp |
PARS |
Director |
|
0 |
2006-10-25 |
2,845,160 |
Premium* |
|
|
Seagen Inc |
SGEN |
Director |
2020-05-15 |
41,503 |
2008-09-22 |
600,559 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Former 10% Beneficial ... |
2011-07-19 |
1,181,967 |
|
0 |
Premium* |
|
|
World Heart Corp |
WHRT |
10% Owner |
2012-08-02 |
0 |
2010-01-26 |
0 |
Premium* |
|
|
Icagen Inc |
ICGN |
|
2011-07-28 |
200,500 |
|
0 |
Premium* |
|
|
Synageva BioPharma Corp |
GEVA |
Former Director |
|
0 |
2012-06-27 |
1,026,832 |
Premium* |
|
|
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
2012-07-24 |
0 |
2012-07-24 |
3,028,439 |
Premium* |
|
|
MEI Pharma Inc |
MEIP |
10% Owner |
2013-02-19 |
2,502,775 |
|
0 |
Premium* |
|
|
Zs Pharma, Inc. |
ZSPH |
Director |
2015-12-17 |
0 |
2014-06-23 |
609,455 |
Premium* |
|
|
aTyr Pharma Inc |
LIFE |
Former 10% Owner, Dire... |
2015-05-12 |
0 |
2015-05-12 |
1,866,126 |
Premium* |
|
|
Aravive Inc |
ARAV |
Director |
2019-12-02 |
31,815 |
2019-12-02 |
576,066 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
Director |
2023-12-21 |
2,666 |
2023-12-21 |
1,786,427 |
Premium* |
|
|
Principia Biopharma Inc |
PRNB |
Director |
2018-09-18 |
0 |
2018-09-18 |
383,480 |
Premium* |
|
|
Chinook Therapeutics Inc |
KDNY |
Director |
2023-08-11 |
0 |
2023-08-11 |
0 |
Premium* |
|
|
Lenz Therapeutics |
LENZ |
10% Owner |
2021-06-29 |
0 |
2022-04-12 |
8,497,067 |
Premium* |
|
|
Scholar Rock Holding Corp |
SRRK |
Director, 10% Owner |
|
0 |
2023-10-16 |
6,788,609 |
Premium* |
|
|
Cargo Therapeutics, Inc. |
CRGX |
10% Owner |
|
0 |
2023-11-14 |
4,121,689 |
Premium* |
|
|
Mineralys Therapeutics, Inc. |
MLYS |
|
2024-02-12 |
0 |
2024-02-12 |
5,074,916 |
Premium* |
|
|
Vtv Therapeutics Inc. |
VTVT |
|
2024-02-27 |
0 |
2024-02-27 |
265,620 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
123 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
Director |
– • – |
2008-05-14 |
4 |
S |
$10.10 |
$1,225,787 |
I/I |
(121,365) |
915,496 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2008-05-15 |
4 |
S |
$10.14 |
$1,001,406 |
I/I |
(98,758) |
842,334 |
0 |
- |
|
| LENZ |
Lenz Therapeutics |
10% Owner |
– – • |
2021-12-15 |
4 |
B |
$10.19 |
$227,533 |
I/I |
22,329 |
7,814,180 |
1.5 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2008-07-28 |
4 |
S |
$10.36 |
$219,964 |
I/I |
(21,232) |
685,702 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2008-05-16 |
4 |
S |
$10.39 |
$436,993 |
I/I |
(42,059) |
811,175 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2008-07-25 |
4 |
S |
$10.81 |
$1,601,350 |
I/I |
(148,136) |
701,432 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2008-07-29 |
4 |
S |
$10.85 |
$1,038,215 |
I/I |
(95,688) |
625,913 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-07-01 |
4 |
AS |
$11.01 |
$50,966 |
I/I |
(4,627) |
1,433,943 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-06-24 |
4 |
AS |
$11.07 |
$539,788 |
I/I |
(48,775) |
1,493,542 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-06-23 |
4 |
AS |
$11.11 |
$565,930 |
I/I |
(50,953) |
1,542,317 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-06-25 |
4 |
AS |
$11.15 |
$612,850 |
I/I |
(54,972) |
1,438,570 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2009-08-18 |
4 |
B |
$11.47 |
$56,260 |
D/D |
4,905 |
10,405 |
2.39 |
- |
|
| VTVT |
Vtv Therapeutics Inc. |
|
– • • |
2024-02-27 |
4 |
A |
$11.81 |
$2,654,085 |
I/I |
224,732 |
265,620 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Director |
– • – |
2021-08-18 |
4 |
B |
$11.98 |
$2,497,830 |
I/I |
208,500 |
3,376,888 |
2.1 |
% |
|
| ARAV |
Aravive Inc |
Director |
– • – |
2016-10-03 |
4 |
B |
$12.25 |
$7,000,005 |
I/I |
571,429 |
571,429 |
2.1 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • – |
2017-03-24 |
4 |
B |
$12.25 |
$7,000,005 |
I/I |
571,429 |
571,429 |
2.1 |
- |
|
| LENZ |
Lenz Therapeutics |
10% Owner |
– – • |
2021-10-15 |
4 |
B |
$12.49 |
$28,727 |
I/I |
2,300 |
7,590,166 |
1.5 |
- |
|
| LENZ |
Lenz Therapeutics |
10% Owner |
– – • |
2021-10-14 |
4 |
B |
$12.50 |
$38,750 |
I/I |
3,100 |
7,587,866 |
1.5 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2007-12-10 |
4 |
S |
$12.63 |
$264,725 |
I/I |
(20,960) |
1,043,112 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2008-09-18 |
4/A |
S |
$12.71 |
$627,594 |
I/I |
(49,378) |
617,871 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2008-09-18 |
4 |
S |
$12.71 |
$264,864 |
I/I |
(20,839) |
617,871 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2008-09-19 |
4 |
S |
$12.74 |
$471,520 |
I/I |
(37,011) |
603,588 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2008-09-19 |
4/A |
S |
$12.74 |
$1,117,247 |
I/I |
(87,696) |
603,588 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2013-05-10 |
4 |
OE |
$12.76 |
$223,300 |
D/D |
17,500 |
27,905 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2008-09-22 |
4 |
S |
$12.79 |
$237,907 |
I/I |
(18,601) |
600,559 |
0 |
- |
|
123 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
